G Bradley Cole, Director at Kiniksa Pharmaceuticals International, sold KNSA on Jul 29, 2026
Data as of Oct 27
▼ SELL$299K3,673 shares at $81.43G Bradley Cole DirectorKNSA Kiniksa Pharmaceuticals International, plc
- Traded
- Jul 29, 2026
- Disclosed
- Jul 31, 2026
- Filed
- 2 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
KNSA since disclosure
+20.0%
after the sale
Similar stocks (XLV) since disclosure
+10.2%
XLV — its sector index fund
Change in closing price from Jul 31, 2026 (the first trading day on or after disclosure) to Oct 27, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.